Barinthus Biotherapeutics: Barinthus Bio Announces Strategic Focus in Immunology and Inflammation (I&I) and Provides a Financial Update
Prioritizing VTP-1000 development in celiac disease, Phase 1 data expected in mid-2025Postponing further clinical development of VTP-300 in chronic hepatitis B (CHB) until a partner is identifiedExten ...
Indian Autos blog43m
Ford and RTR Team Up for the Most Enthusiast-Focused Mustang Yet
Ford has unveiled the Mustang RTR, a high-performance turbocharged Mustang built for enthusiasts, ahead of the 2025 Detroit ...